Skip to content

Connected Health Blood Pressure Monitoring In Stroke and TIA Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02450760
Acronym
CHAMPS
Enrollment
33
Registered
2015-05-21
Start date
2015-11-30
Completion date
2021-07-31
Last updated
2022-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Attack, Transient, Stroke

Brief summary

The goal of this pilot project is to assess adherence with home blood pressure monitoring in hypertensive patients with a history of cerebral infarction and to determine if a social incentive improves adherence with monitoring. Enrolled subjects will all have a history of cerebral infarction and uncontrolled blood pressure, defined by SBP\>140 or DBP\>90 mm Hg at the time of enrollment. To be eligible subjects will also be required to own a smart phone (iOS or Android operating system). After enrollment, patients will be given a home blood pressure cuff with instructions to monitor their BP twice daily for 90 days. Subjects will be randomly assigned to a social incentive program, in which a social supporter receives updates via email and/or text message on the subject's adherence with BP monitoring and their average blood pressure. This study will provide important pilot data which will inform the design of future studies utilizing connected health and automated systems to improve home blood pressure monitoring and blood pressure control in patients with a history of stroke.

Interventions

Quantify adherence to 90 days of home blood pressure monitoring and to determine if a social incentive improves adherence

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult, age ≥ 18 years * History of ischemic stroke or high risk TIA (defined by ABCD2 ≥ 4)between 2 weeks and 12 months prior to enrollment * Hypertensive at time of enrollment, defined by SBP\>140 mm Hg or DBP \>90 mm Hg at the time of study screening * Must own a smart phone capable of interacting with the connected blood pressure cuff (Apple iPhone 3GS or higher; Android 4.0 or higher with Bluetooth connectivity) * Willingness and ability to sign informed consent by patient

Exclusion criteria

* Moderate or severe disability, defined by modified Rankin Scale ≥ 3. * Expected residence in a rehabilitation hospital, nursing facility or assisted living community during the study period. * Upper arm circumference \<9 inches or \>17 inches * Inability to monitor BP in both of the upper arms (i.e. history of bilateral radical mastectomy, bilateral severe subclavian stenosis, or bilateral arterial venous fistulas for dialysis). * Blood pressure discrepancy between arms of \>10 mm Hg. * Inability to follow-up at 90 days and return BP monitor * Active participation in another clinical trial * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Adherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed90 DaysPercentage of requested blood pressure measurements completed. Note that subjects were enrolled for 90 +/- 7 days, and so this calculation was completed at day 83, rather than day 90.

Secondary

MeasureTime frameDescription
Number of Physician Visits90 days
Number of Emergency Department Visits90 days
Number of Changes in Antihypertensive Medications (Dose Adjustment or Addition of a New Agent)90 days
Change in Systolic Blood Pressure Over Study Period90 daysDifference in systolic blood pressure from the first 7 days of measurement to the last 7 days of measurement for each subject
Number of Patients That Perceived Blood Pressure Monitoring to be Useful90 daysNumber of participants who felt that BP monitoring was useful or very useful
Number of Patients Who Felt They Had Well-controlled Blood Pressure90 daysPatients perception of whether or not BP was well controlled
Number of Participates That Perceived the Blood Pressure Monitoring Device to be Easy to Use90 daysNumber of patients who felt that device was easy or very easy to use

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Subjects will take their blood pressure twice daily using the provided Withings blood pressure cuff. If subjects miss blood pressure readings, they will receive automated alerts reminding them to take their blood pressure. Subjects will also receive weekly emails with their blood pressure data for the week. Social incentive: Quantify adherence to 90 days of home blood pressure monitoring and to determine if a social incentive improves adherence
15
Social Incentive
Subjects will take their blood pressure twice daily using the provided Withings blood pressure cuff. Subjects in this arm will also identify a social supporter who may help subjects adhere to daily blood pressure readings. If the subject misses blood pressure readings, they will receive automated alerts reminding them to take their blood pressure. The identified social supporter will also receive these alerts, with the expectation that the social supporter will remind the subject to take their blood pressure. Both the subject and the social supporter will also receive weekly emails with their blood pressure data for the week. Social incentive: Quantify adherence to 90 days of home blood pressure monitoring and to determine if a social incentive improves adherence
18
Total33

Baseline characteristics

CharacteristicControlTotalSocial Incentive
Age, Continuous58.4 years
STANDARD_DEVIATION 9.3
58.9 years
STANDARD_DEVIATION 8.8
59.4 years
STANDARD_DEVIATION 8.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
9 Participants16 Participants7 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants16 Participants10 Participants
Region of Enrollment
United States
15 participants33 participants18 participants
Sex: Female, Male
Female
8 Participants19 Participants11 Participants
Sex: Female, Male
Male
7 Participants14 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 18
other
Total, other adverse events
0 / 150 / 18
serious
Total, serious adverse events
0 / 150 / 18

Outcome results

Primary

Adherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed

Percentage of requested blood pressure measurements completed. Note that subjects were enrolled for 90 +/- 7 days, and so this calculation was completed at day 83, rather than day 90.

Time frame: 90 Days

Population: All enrolled subjects

ArmMeasureValue (MEDIAN)
ControlAdherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed40 percentage of requested BP measurements
Social IncentiveAdherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed60 percentage of requested BP measurements
p-value: 0.29Wilcoxon (Mann-Whitney)
Secondary

Change in Systolic Blood Pressure Over Study Period

Difference in systolic blood pressure from the first 7 days of measurement to the last 7 days of measurement for each subject

Time frame: 90 days

Population: Enrolled subjects

ArmMeasureValue (MEAN)Dispersion
ControlChange in Systolic Blood Pressure Over Study Period3.1 mm HgStandard Deviation 14
Social IncentiveChange in Systolic Blood Pressure Over Study Period2.7 mm HgStandard Deviation 14.6
p-value: 0.95t-test, 2 sided
Secondary

Number of Changes in Antihypertensive Medications (Dose Adjustment or Addition of a New Agent)

Time frame: 90 days

Population: subjects completing day 90 interview

ArmMeasureValue (MEDIAN)
ControlNumber of Changes in Antihypertensive Medications (Dose Adjustment or Addition of a New Agent)0 Number of changes to BP medications
Social IncentiveNumber of Changes in Antihypertensive Medications (Dose Adjustment or Addition of a New Agent)0 Number of changes to BP medications
Secondary

Number of Emergency Department Visits

Time frame: 90 days

Population: Subjects who completed day 90 interview

ArmMeasureValue (MEDIAN)
ControlNumber of Emergency Department Visits0 Number of ED visits
Social IncentiveNumber of Emergency Department Visits1 Number of ED visits
Secondary

Number of Participates That Perceived the Blood Pressure Monitoring Device to be Easy to Use

Number of patients who felt that device was easy or very easy to use

Time frame: 90 days

Population: 24 subjects completed 90 day survey

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participates That Perceived the Blood Pressure Monitoring Device to be Easy to Use9 Participants
Social IncentiveNumber of Participates That Perceived the Blood Pressure Monitoring Device to be Easy to Use9 Participants
p-value: 0.15Chi-squared
Secondary

Number of Patients That Perceived Blood Pressure Monitoring to be Useful

Number of participants who felt that BP monitoring was useful or very useful

Time frame: 90 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Patients That Perceived Blood Pressure Monitoring to be Useful4 Participants
Social IncentiveNumber of Patients That Perceived Blood Pressure Monitoring to be Useful3 Participants
p-value: 0.83Chi-squared
Secondary

Number of Patients Who Felt They Had Well-controlled Blood Pressure

Patients perception of whether or not BP was well controlled

Time frame: 90 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Patients Who Felt They Had Well-controlled Blood Pressure10 Participants
Social IncentiveNumber of Patients Who Felt They Had Well-controlled Blood Pressure9 Participants
p-value: 0.26Chi-squared
Secondary

Number of Physician Visits

Time frame: 90 days

Population: Subjects who completed day 90 interview

ArmMeasureValue (MEDIAN)
ControlNumber of Physician Visits2 physician visits
Social IncentiveNumber of Physician Visits3 physician visits

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026